Assistant Professor, Medicine, Boston University School of Medicine
Cardiology
Dr. Jared W. Magnani, MD
|
|
Give Review
Jared Magnani is an expert in the field of Cardiology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care Jared Magnani is a published doctor. He published 51 publications, including: 'Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium.' He is registered with Medicare.
Publications
- Inflammation as a Mediator of the Association Between Race and Atrial Fibrillation: Results from the Health, Aging, and Body Composition Study.
- Atrial Flutter - Clinical Risk Factors and Adverse Outcomes in the Framingham Heart Study.
- P-wave indices and atrial fibrillation: Cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study.
- A Common SCN5A Variant Is Associated with PR Interval and Atrial Fibrillation Among African Americans.
- The MESA Heart failure risk score: can't we do more?
- Biomarkers in Lone Atrial Fibrillation-An Additional 'Fine Tuning' of Risk?
- B-type natriuretic peptide and C-reactive protein in the prediction of Atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
- Urinary Kidney Injury Molecule 1 (KIM-1) and Interleukin 18 (IL-18) as Risk Markers for Heart Failure in Older Adults: The Health, Aging, and Body Composition (Health ...
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study.
- Gene Expression and Genetic Variation in Human Atria.
- Reciprocal relations between physical disability, subjective health, and atrial fibrillation: The Framingham Heart Study.
- Obesity begets Atrial fibrillation: a contemporary summary.
- The QT Interval and Risk of Incident Atrial Fibrillation.
- Risk assessment for incident Heart failure in individuals with atrial fibrillation.
- Common genetic variation near the connexin-43 gene is associated with resting Heart rate in African Americans: A genome-wide association study of 13,372 participants.
- Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation.
- Meta-analysis identifies six new susceptibility loci for Atrial fibrillation.
- Plasma resistin, adiponectin, and risk of incident Atrial fibrillation: The Framingham Offspring Study.
- White Blood Cell Count and Risk of Incident Atrial Fibrillation (From the Framingham Heart Study).
- Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
- Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study).
- Vitamin D status is not related to development of Atrial fibrillation in the community.
- Large-Scale Candidate Gene Analysis in Whites and African-Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The NHLBI CARe Project.
- Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
- P Wave Indices, Obesity, and the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study.
- P wave duration and risk of longitudinal atrial fibrillation in Persons ≥ 60 years old (from the Framingham Heart Study).
- Dietary factors and incident atrial fibrillation: the Framingham Heart Study.
- P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.
- Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.
- Association between familial Atrial fibrillation and risk of new-onset Atrial fibrillation.
- P-wave indices: derivation of reference values from the Framingham Heart Study.
- Cardiovascular epidemiology of postinfarction Angina and menopause age.
- Genetics of Atrial fibrillation: implications for future research directions and personalized medicine.
- Genome-wide association study of PR interval.
- Relations of biomarkers of distinct pathophysiological pathways and Atrial fibrillation incidence in the community.
- P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).
- P wave indices: current status and future directions in epidemiology, clinical, and research applications.
- Myocarditis: current trends in diagnosis and treatment.
- Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors.
- Care at the end of life: a novel curriculum module implemented by medical students.
- Atrial fibrillation patterns and risks of subsequent stroke, Heart failure, or death in the community.
- Assessment of reproducibility - automated and digital caliper ECG measurement in the Framingham Heart Study.
- Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for Atrial fibrillation.
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.
- Genome-wide association studies of the PR interval in African Americans.
- Whole blood gene expression and atrial fibrillation: the framingham Heart study.
- Blood lipids and the incidence of atrial fibrillation: the multi-ethnic study of atherosclerosis and the framingham Heart study.
- Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium.
Schools
Stanford University
Massachusetts General Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Education
-
Boston University Medical Center -
Massachusetts General Hospital -
Stanford University School of Medicine
Hospital
-
Boston Medical Center
Drug Facts
| NPI NUMBER | 1306996343 | |
| NPPES Provider LastName | MAGNANI | |
| NPPES Provider FirstName | JARED | |
| NPPES Provider ZIPCode | 021182309 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 285.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306996343 |
| Last Name Of The Provider | MAGNANI |
| First Name Of The Provider | JARED |
| View All |
Similar Doctors
|
|
Dr. Jennifer Lewey, MD |
|
|
Dr. Paul F. Hwang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron Blankstein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sarah B. Tsiaras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Loscalzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjukta Sanyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Weintraub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert T. Eberhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayan R. Patel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Naomi M. Hamburg, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|